IRTC iRhythm Technologies Inc
- Stocks
- Healthcare
- NASDAQ: IRTC
Price (delayed)
$164.97
Market cap
$5.3B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.93
Enterprise value
$5.72B
iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based
Highlights
The EPS has increased by 31% YoY and by 7% from the previous quarter
The company's net income rose by 30% YoY and by 6% QoQ
The quick ratio has contracted by 27% YoY and by 12% from the previous quarter
Key stats
What are the main financial stats of IRTC
Market
Valuations
Earnings
Shares outstanding
32.13M
Market cap
$5.3B
Enterprise value
$5.72B
Price to earnings (P/E)
N/A
Price to book (P/B)
50.81
Price to sales (P/S)
8.03
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.7
Revenue
$657.23M
Gross profit
$458.62M
Operating income
-$105.65M
Net income
-$92.43M
EBIT
-$78.41M
EBITDA
-$52.28M
Free cash flow
$27.88M
Per share
Balance sheet
Liquidity
EPS
-$2.93
EPS diluted
-$2.93
Free cash flow per share
$0.87
Book value per share
$3.25
Revenue per share
$20.54
TBVPS
$30.11
Total assets
$964.03M
Total liabilities
$860.37M
Debt
$734.74M
Equity
$103.66M
Working capital
$531.71M
Debt to equity
7.09
Current ratio
5.02
Quick ratio
4.81
Net debt/EBITDA
-7.98
Margins
Efficiency
Dividend
EBITDA margin
-8%
Gross margin
69.8%
Net margin
-14.1%
Operating margin
-16.1%
Return on assets
-9.9%
Return on equity
-104.7%
Return on invested capital
-6.9%
Return on capital employed
-9.4%
Return on sales
-11.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IRTC stock price
How has the iRhythm Technologies stock price performed over time
Intraday
17.68%
1 week
22.95%
1 month
13.03%
1 year
95.88%
YTD
82.95%
QTD
7.15%
Financial performance
How have iRhythm Technologies's revenue and profit performed over time
Revenue
$657.23M
Gross profit
$458.62M
Operating income
-$105.65M
Net income
-$92.43M
Gross margin
69.8%
Net margin
-14.1%
The net margin is up by 42% YoY and by 11% from the previous quarter
IRTC's operating margin is up by 32% YoY and by 10% from the previous quarter
The company's net income rose by 30% YoY and by 6% QoQ
The company's gross profit rose by 27% YoY and by 7% QoQ
Price vs fundamentals
How does IRTC's price correlate with its fundamentals
Growth
What is iRhythm Technologies's growth rate over time
Valuation
What is iRhythm Technologies stock price valuation
P/E
N/A
P/B
50.81
P/S
8.03
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.7
The EPS has increased by 31% YoY and by 7% from the previous quarter
IRTC's P/B is 143% above its 5-year quarterly average of 20.9 and 37% above its last 4 quarters average of 37.2
IRTC's equity is up by 20% since the previous quarter and by 4.5% year-on-year
The P/S is 49% above the last 4 quarters average of 5.4 but 16% below the 5-year quarterly average of 9.6
The revenue has grown by 22% YoY and by 6% from the previous quarter
Efficiency
How efficient is iRhythm Technologies business performance
IRTC's return on invested capital has surged by 60% year-on-year and by 12% since the previous quarter
The ROA has grown by 49% YoY and by 7% from the previous quarter
The ROS has increased by 48% YoY and by 13% from the previous quarter
iRhythm Technologies's ROE has decreased by 23% YoY but it has increased by 7% from the previous quarter
Dividends
What is IRTC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IRTC.
Financial health
How did iRhythm Technologies financials performed over time
IRTC's total assets is 12% greater than its total liabilities
The quick ratio has contracted by 27% YoY and by 12% from the previous quarter
The current ratio has declined by 27% year-on-year and by 12% since the previous quarter
IRTC's equity is up by 20% since the previous quarter and by 4.5% year-on-year
The debt to equity has contracted by 16% from the previous quarter and by 4.6% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.